Demonstrating Comparative In Vitro Bioequivalence for Animal Drug Products Through Chemistry and Manufacturing Controls and Physicochemical Characterization: A Proposal

Journal Title: The AAPS Journal - Year 2015, Vol 17, Issue 2

Abstract

The assessment of in vivo bioequivalence (BE) of nonsystemically absorbed drug products has been a longstanding challenge facing drug manufacturers and regulators of human or animal health products. Typically, in situations where blood level BE studies are not feasible, clinical endpoint BE trials have provided the only option for generating interproduct comparisons. Given the imprecision and logistic challenges associated with these studies, there has been an effort to identify alternative pathways that can reliably ensure the equivalence of product performance and quality. This commentary provides a proposal for an in vitro approach for evaluating the in vivo BE of veterinary drug products that are either nonsystemically absorbed or that act both locally and systemically but where the local site of action is proximal to the absorption window. The assumption underlying this approach is that equivalence in product physicochemical attributes and in vitro product performance translates to equivalence in product in vivo behavior. For sponsors with a right of reference to underlying safety and effectiveness data, this approach could be used to support pre and post-approval changes. When comparing a generic test product to the pioneer (reference listed new animal drug, RLNAD) product, a demonstration of sameness across a battery of in vitro test procedures could be used to confirm that the test and RLNAD products are bioequivalent.

Authors and Affiliations

Marilyn N. Martinez, Raafat Fahmy

Keywords

Related Articles

Effects of Surface Composition on the Aerosolisation and Dissolution of Inhaled Antibiotic Combination Powders Consisting of Colistin and Rifampicin

The online version of this article (doi:10.1208/s12248-015-9848-z) contains supplementary material, which is available to authorized users.

Structural and Activity Profile Relationships Between Drug Scaffolds

The online version of this article (doi:10.1208/s12248-015-9737-5) contains supplementary material, which is available to authorized users.

Development and characterization of biodegradable chitosan films for local delivery of paclitaxel

Intratumoral and local drug delivery strategies have gained momentum recently as a promising modality in cancer therapy. In order to deliver paclitaxel at the tumor site in therapeutically relevant concentrations, chitos...

Comparative evaluation of tableting compression behaviors by methods of internal and external lubricant addition: Inhibition of enzymatic activity of trypsin preparation by using external lubricant addition during the tableting compression process

This study evaluated tableting compression by using internal and external lubricant addition. The effect of lubricant addition on the enzymatic activity of trypsin, which was used as a model drug during the tableting com...

Toward Global Standards for Comparator Pharmaceutical Products: Case Studies of Amoxicillin, Metronidazole, and Zidovudine in the Americas

The online version of this article (doi:10.1208/s12248-012-9350-9) contains supplementary material, which is available to authorized users.

Download PDF file
  • EP ID EP680917
  • DOI  10.1208/s12248-014-9702-8
  • Views 42
  • Downloads 0

How To Cite

Marilyn N. Martinez, Raafat Fahmy (2015). Demonstrating Comparative In Vitro Bioequivalence for Animal Drug Products Through Chemistry and Manufacturing Controls and Physicochemical Characterization: A Proposal. The AAPS Journal, 17(2), -. https://europub.co.uk/articles/-A-680917